SCHEMBL5030173

SCHEMBL5030173

CC(O)Cc1ccccc1-c1cccc(Br)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.42
PTGER1 P34995 2/20 0.41
PTGER4 P35408 2/20 0.41
PTGER3 P43115 2/20 0.41
PTGER2 P43116 2/20 0.41
MAOB P27338 1/20 0.38
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
KCNA5 P22460 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MME P08473 1/20 0.35
ACE P12821 1/20 0.35
CPA1 P15085 1/20 0.35
ACE2 Q9BYF1 1/20 0.35
MAPK1 P28482 1/20 0.35
TP53 P04637 1/20 0.35
TSHR P16473 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2862508 0.83 PTGER1 (0.45) KMT2APTGER1PTGER4PTGER3PTGER2
SCHEMBL5272384 0.81 KMT2A (0.61) KMT2APTGER1PTGER4PTGER3PTGER2
SCHEMBL4375768 0.79 KMT2A (0.53) KMT2APTGER1PTGER4PTGER3PTGER2
SCHEMBL5912626 0.78 PDCD1 (0.50) KMT2APTGER1PTGER4PTGER3PTGER2
SCHEMBL2870992 0.73 KMT2A (0.47) KMT2AKCNA5MMEACECPA1
SCHEMBL1338716 0.73 KMT2A (0.47) KMT2APTGER1PTGER4PTGER3PTGER2
SCHEMBL9890646 0.73 PTGER1 (0.57) KMT2APTGER1PTGER4PTGER3PTGER2
SCHEMBL29398181 0.73 RAB9A (0.50) KMT2AMAOBMEN1NPC1SMN1; SMN2
SCHEMBL5805651 0.73 RAB9A (0.50) KMT2AMAOBMEN1NPC1SMN1; SMN2
SCHEMBL1337563 0.72 CD274 (0.47) KMT2APTGER1PTGER4PTGER3PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101360714-A Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies ASTRAZENECA AB (SE) 2009-02-04 CN disclosed
EP-1957462-A2 NOVEL 2-AMINO-HETEROCYCLES UDEFUL IN THE TREATMENT OF ABETA-RELATED PATHOLOGIES Astra Zeneca AB (SE) 2008-08-20 EP disclosed
WO-2007058583-A2 NOVEL 2-AMINO-HETEROCYCLES USEFUL IN THE TREATMENT OF ABETA-RELATED PATHOLOGIES ASTRAZENECA AB (SE) 2007-05-24 WO disclosed